Antisense antiviral compound and method for treating Arenavirus infection

Details for Australian Patent Application No. 2007223776 (hide)

Owner AVI BioPharma, Inc. The Scripps Research Institute

Inventors Buchmeier, Michael; Neuman, Benjamin; Iversen, Patrick L.; Stein, David A.

Agent FB Rice

Pub. Number AU-A-2007223776

PCT Pub. Number WO2007/103529

Priority 60/780,228 07.03.06 US

Filing date 7 March 2007

Wipo publication date 13 September 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/07 (2006.01)

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

9 October 2008 Alteration of Name

  The name of the applicant has been altered to AVI BioPharma, Inc.; The Scripps Research Institute

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/103529 Priority application(s): WO2007/103529

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007223787-Combination therapy with non-selective COX inhibitors to prevent COX-related gastric injuries

2007223742-Rotating perforated cylinder treatment system